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Abstract:  Staphylococcus aureus  produces  a wide variety of toxins including 
staphylococcal enterotoxins (SEs; SEA to SEE, SEG  to  SEI, SER  to  SET)  with 
demonstrated emetic activity, and staphylococcal-like (SEl) proteins, which are not emetic 
in a primate model (SElL and SElQ) or have yet to be tested (SElJ, SElK, SElM to SElP, 
SElU, SElU2 and SElV). SEs and SEls have been traditionally subdivided into classical 
(SEA to SEE) and new (SEG to SElU2) types. All possess superantigenic activity and are 
encoded by accessory genetic elements, including plasmids, prophages, pathogenicity 
islands,  vSa genomic islands, or by genes located next to the  staphylococcal cassette 
chromosome (SCC) implicated in methicillin resistance. SEs are a major cause of food 
poisoning, which typically occurs after ingestion of different foods, particularly processed 
meat and dairy products, contaminated with S. aureus  by improper handling and 
subsequent storage at elevated temperatures. Symptoms are of rapid onset  and include 
nausea and violent vomiting, with or without diarrhea. The illness is usually self-limiting 
and only occasionally it is  severe enough to warrant hospitalization.  SEA is the most 
common cause of staphylococcal food poisoning worldwide, but the involvement of other 
classical SEs has been also demonstrated. Of the new SE/SEls, only SEH have clearly been 
associated with food poisoning. However, genes encoding novel SEs as well as SEls with 
untested emetic activity are widely represented in S. aureus, and their role in pathogenesis 
may be underestimated. 
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1. Staphylococcal Food Poisoning 
Staphylococcal food poisoning (SFP) is an intoxication that results from the consumption of foods 
containing sufficient amounts of one (or more) preformed enterotoxin [1,2]. Symptoms of SFP have a 
rapid onset (2–8  h),  and  include  nausea,  violent vomiting,  abdominal cramping, with  or  without 
diarrhea [3–5]. The disease is usually self-limiting and typically resolves within 24–48 h after onset. 
Occasionally it can be severe enough to warrant hospitalization, particularly when infants, elderly or 
debilitated people are concerned [4]. 
Food handlers carrying enterotoxin-producing S. aureus in their noses or on their hands are regarded as 
the main source of food contamination, via manual contact or through respiratory secretions. In fact,  
S. aureus is a common commensal of the skin and mucosal membranes of humans, with estimates of  
20–30% for persistent and 60% for intermittent colonization [6]. Because S. aureus does not compete 
well with indigenous microbiota in raw foods, contamination is mainly associated with improper handling 
of cooked or processed foods, followed by storage under conditions which allow growth of S. aureus and 
production of the enterotoxin(s). However, S. aureus is also present in food animals, and dairy cattle, 
sheep and goats, particularly if affected by subclinical mastitis, are likely contaminants of milk [7]. Air, 
dust,  and  food contact surfaces can also serve as vehicles in the transfer of S. aureus  
to foods. 
Foods that have been frequently incriminated in staphylococcal intoxication include meat and meat 
products,  poultry and egg products, milk and dairy products, salads, bakery products, particularly 
cream-filled pastries and cakes, and sandwich fillings [8,9]. Salted food products, such as ham, have 
also been implicated [10], according to the capacity of S. aureus to grow at relatively low water activity 
(aw = 0.86; [11]). 
SFP is a common disease whose real incidence is probably underestimated for a number of reasons, 
which include misdiagnosis, unreported minor outbreaks, improper sample collection and improper 
laboratory examination. The control of this disease is of social and economic importance. In fact, it 
represents a considerable burden in terms of loss of working days and productivity, hospital expenses, 
and economical losses in food industries, catering companies and restaurants [2,3,12–15]. 
2. Staphylococcus aureus Enterotoxins 
The S. aureus enterotoxins (SEs) are potent gastrointestinal exotoxins synthesized by S. aureus 
throughout the logarithmic  phase of growth or during the transition from the exponential to the 
stationary phase [16–20]. They are active in high nanogram to low microgram quantities [21], and are 
resistant to conditions (heat treatment, low pH) that easily destroy the bacteria that produce them, and 
to proteolytic enzymes, hence retaining their activity in the digestive tract after ingestion [22–24]. 
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Table 1. General properties of SEs and SEls and genomic location of the encoding genes. 
See text for references.  nd, not determined; 
a  Emetic activity demonstrated in rabbits   
(SElL; [43]) or in the small insectivore Suncus murinus (SElP; [39]) but not in a primate 
model; 
b Hypothetical location in a prophage [48]. 
Toxin 
Molecular 
Mass (kDa) 
Emetic 
Activity 
Crystal 
Structure Solved 
Gene  Accessory genetic element 
SEA  27.1  yes  yes  sea  ΦSa3ms, ΦSa3mw, Φ252B, ΦNM3, ΦMu50a 
SEB  28.4  yes  yes  seb  pZA10, SaPI3 
SEC  27.5–27.6  yes  yes  sec  SaPIn1, SaPIm1, SaPImw2, SaPIbov1 
SED  26.9  yes  yes  sed  pIB485-like 
SEE  26.4  yes  no  see  ΦSa 
b 
SEG  27.0  yes  yes  seg  egc1 (vSaβ I); egc2 (vSaβ III); egc3; egc4 
SEH  25.1  yes  yes  seh  MGEmw2/mssa476 seh/∆seo 
SEI  24.9  weak  yes  sei  egc1 (vSaβ I); egc2 (vSaβ III) ); egc3 
SElJ  28.5  nd  no  selj  pIB485-like; pF5 
SElK  26.0  nd  yes  selk  ΦSa3ms, ΦSa3mw, SaPI1, SaPI3, SaPIbov1, SaPI5 
SElL  26.0  no 
a  no  sell  SaPIn1, SaPIm1, SaPImw2, SaPIbov1 
SElM  24.8  nd  no  selm  egc1 (vSaβ I); egc2 (vSaβ III) 
SElN  26.1  nd  no  seln  egc1 (vSaβ I); egc2 (vSaβ III); egc3; egc4 
SElO  26.7  nd  no  selo 
egc1 (vSaβ I); egc2 (vSaβ III); egc3; egc4; 
MGEmw2/mssa476 seh/∆seo 
SElP  27.0  nd 
a  no  selp  ΦN315, ΦMu3A 
SElQ  25.0  no  no  selq  ΦSa3ms, ΦSa3mw, SaPI1, SaPI3, SaPI5 
SER  27.0  yes  no  ser  pIB485-like; pF5 
SES  26.2  yes  no  ses  pF5 
SET  22.6  weak  no  set  pF5 
SElU  27.1  nd  no  selu  egc2 (vSaβ III); egc3 
SElU2 
(SEW) 
nd  nd  no  selu2  egc4 
SElV  nd  nd  no  selv  egc4 
2.1. Nomenclature 
SEs belong to the broad family of pyrogenic toxin superantigens (SAgs; [3]). SAgs bypass 
conventional antigen recognition by interaction with major histocompatibility complex (MHC) class II 
molecules on the surface of antigen presenting cells, and with T-cell receptors (TCR) on specific  
T-cell subsets. Interaction typically occurs to the variable region of the TCR β chain (Vβ) but binding 
to the TCR Vα domain has been reported [21,25,29]. This leads to activation of a large number of  
T-cells followed by proliferation and massive release of chemokines and proinflammatory cytokines 
that may led to potentially lethal toxic shock syndrome [3]. However, staphylococcal enterotoxins have 
been proposed to be named according to their emetic activities [30]. Only SAgs that induce vomiting 
after oral administration in a primate model will be designated as SEs. Related toxins that lack emetic 
activity or have not been tested for it should be designated as staphylococcal enterotoxin-like (SEls) 
SAgs. Also, newly discovered toxins with more than 90% amino acid sequence identity with existing Toxins 2010, 2     
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SEs or SEls should be designated as a numbered subtype. However, despite this consensus 
nomenclature some subtypes are still just called variants. 
At the time of this review, the repertoire of S. aureus SEs/SEls comprised 22 members, excluding 
molecular variants: (i) the classical SEA, SEB, SEC (with the SEC1, SEC2 and SEC3, SEC ovine and 
SEC bovine variants), SED and SEE, which were discovered in studies of S. aureus strains involved in 
SFP outbreaks, and classified in distinct serological types [31–35]; and (ii) the new types of SEs (SEG, 
SEH, SEI, SER, SES, SET) and SEls (SElJ, SElK, SElL, SElM, SElN, SElO, SElP, SElQ, SElU, 
SElU2, and SElV) [28,36–45]. TSST-1, the toxic shock staphylococcal toxin, initially designated as 
SEF, lacks emetic activity [46,47]. 
2.2. Structure 
SEs and SEls constitute a family of structurally related exoproteins that range in size from ~22 to  
28 kDa (Table 1). Based on amino acid sequence comparisons, they have been distributed into four or 
five groups (Table 2), depending on the inclusion or not of SEH within group 1 [21,29,40,49]. The 
recently described SET is most related to a putative exotoxin from an S. aureus isolate involved in 
bovine mastitis, and to streptococcal pyrogenic toxin type K (SpeK) [40].  TSST-1, which is 
functionally a superantigen with no emetic activity, is more distant to SEs and SEls than to SSLs 
(staphylococcal superantigen-like proteins) [50]. The SSLs, first identified by screening staphylococcal 
genomes using two conserved amino acid motifs placed in the N-terminal and   
C-terminal domains of SAgs, are not mitogenic to T cells and do not bind MHC class II, although they 
display a wide array of activities targeting key elements of the innate and specific immunity, such as 
neutrophils, complement factor C5, and IgA [51–56]. 
Table 2. Grouping of SEs and SEls based on amino acid sequence comparisons. Modified 
from Larkin et al. [21]. Enterotoxins encoded by the egc cluster are shown in bold. SEH (in 
parenthesis) has been placed within Group 1 or Group 5, depending on the author [29,49]. 
Group  SEs and SEls 
Group 1  SEA, SED, SEE, (SEH), SElJ, SElN, SElO, SElP, SES  
Group 2  SEB, SEC, SEG, SER, SElU, SElU2 
Group 3  SEI, SElK, SElL, SElM, SElQ, SElV  
Group 4  SET 
(Group 5)  (SEH) 
The three-dimensional structures of TSST-1 [57,58] and several SEs and SEls [59–69] have been 
solved by crystallography (Table 1). The structures are remarkably conserved, although they interact 
differently with MHC class II molecules, and show different TCR specificity [70]. They are compact 
ellipsoidal proteins with two unequal domains separated by a shallow grove. The larger C-terminal 
domain is a β-grasp fold consisting of four- to five-strand β-sheet that packs against a highly conserved 
α-helix [71]. The smaller N-terminal domain consists of a mixed β-barrel with Greek-key topology, 
similar to the  OB (oligosaccharide/oligonucleotide  binding)-fold  [72]  also  found in many other 
bacterial toxins (SSLs, streptococcal superantigens, nucleases and toxins of the AB5 family, including 
cholera and pertussis toxins, and verotoxin) [29,50]. The two domains are stabilized by close packing Toxins 2010, 2     
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and by a section of the N-terminus that extends over the top of the C-terminal domain. The N-terminal 
extension contributes substantially to the TCR-binding site, located in the cleft between the two protein 
domains, while the MHC class II binding site is in the OB-fold  [29,50]. The top of the   
N-terminal domain usually contains a highly flexible disulfide loop, which has been implicated with 
emetic activity (see below). 
2.3. Mode of Action 
Important efforts have been made to identify specific amino acids and domains within SEs which 
may be important for emesis, but results are still limited and controversial. Like TSST-1, SElL, and 
SElQ  are  nonemetic, while SEI  displays  weak emetic activity  [38,41,42]. These  toxins  lack  the 
disulfide loop characteristically found at the top of the N-terminal domain of other SEs. Nonetheless, 
the loop itself does not appear to be an absolute requirement for emesis, although it may stabilize a 
crucial conformation important for this activity [73]. Carboxymethylation of histidines on SEA or SEB 
generates proteins devoid of enterotoxicity, which still retain superantigenicity [75,76]. Analysis of the 
effects of carboxymethylation of each of the SEA histidines revealed that His61 is important for 
emesis, but not for T-cell proliferation [77]. Conversely, Leu48Gly and Phe44Ser mutant forms of SEA 
and SEB, respectively, do not bind MHC class II molecules or cause T-cell activation, but still provoke 
vomiting [78], hence separating emesis and superantigenicity as different functions of the proteins. 
Despite this, a high correlation exists between the two activities since, in most cases, genetic mutations 
resulting in a loss of superantigen activity also results in loss of emetic activity [78]. 
In contrast to the case of many other bacterial enterotoxins, specific cells and receptors in the 
digestive system have not been unequivocally linked to oral intoxication by a SE. It has been suggested 
that SEs stimulate the vagus nerve in the abdominal viscera, which transmits the signal to the vomiting 
center in the brain [79]. Supporting this idea, receptors on vagal afferent neurons are essential for SEA-
triggered emesis [80], and capsaicin, a small molecular weight compound from chilli peppers that 
depletes peptidergic sensory nerve fibers, also diminishes SE effects in mammals [21]. In addition, SEs 
are able to penetrate the gut lining and activate local and systemic immune responses [81]. Release of 
inflammatory mediators (including histamine, leukotrienes, and neuroenteric peptide substance P) 
causes vomiting [82–85]  and the emetic response can be eliminated by H2-  and calcium   
channel-blockers, which also block the release of histamine [86]. Local immune system activation 
could also be responsible for the gastrointestinal damage associated with SE ingestion [87,88]. 
Inflammatory changes are observed in several regions of the gastrointestinal tract, but the most severe 
lesions appear in the stomach and the upper part of the small intestine [89]. The diarrhea sometimes 
associated with SEs intoxication may be due to the inhibition of water and electrolyte reabsorption in 
the small intestine [90,91]. In an attempt to link the two distinct activities of SEs, i.e., superantigenicity 
and enterotoxicity, it has been postulated that enterotoxin activity could facilitate transcitosis, enabling 
the toxin to enter the bloodstream and circulate through the body, thus allowing the interaction with 
antigen presenting- and T-cells that leads to superantigen activity [3,92]. In this way, circulation of SEs 
following ingestion of SEs as well as their spread from a S. aureus infection site, could have more 
profound effects upon the host versus if the toxin remains localized [21]. Toxins 2010, 2     
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2.4. Enterotoxin Gene Location 
All se and sel genes are located on accessory genetic elements, including plasmids, prophages,  
S. aureus pathogenicity islands (SaPIs), genomic island vSa, or next to the staphylococcal cassette 
chromosome (SCC) elements (Table 1). Most of these are mobile genetic elements, and their spread 
among S. aureus isolates can modify their ability to cause disease and contribute to the evolution of 
this important pathogen. 
2.4.1. Plasmids 
Plasmids have been long recognized as efficient vehicles for the spread of resistance and virulence 
determinants through horizontal gene transfer. In S. aureus, two kinds of plasmids carrying se/sel genes 
have been characterized  (Table  1; Figure 1). Both contain sej  and  ser  associated with either  sed 
(pIB485-like) or with ses and set (pF5) [40,45,93]. 
Figure 1. Enterotoxin and enterotoxin-like genes in plasmids pIB485 and pF5 based on 
sequencing data deposited under the accession numbers indicated to the right of the figure.  
Note that
  pIB485 also contains blaZ  and  cad  resistance genes [94] and probably   
ser [40,95]. 
other
transcriptional regulator, MarR family
lantibiotic biosynthesis genes
ABC transporter
alcohol dehydrogenase gene
enterotoxin genes
pIB485
pF5 
≈600-800 nt
KSI1410 M94872.1, AF053140.1  
Strain            Accession number Plasmid
Fukuoka 5            AB330135.1
 
The first plasmid described to carry an enterotoxin gene was pIB485, a 27.6 kilobase (kb) plasmid, 
in which first sed and latter selj were identified [45,94]. Enterotoxin SER was discovered by [93] in  
S. aureus strains associated with a food poisoning outbreak that occurred in Fukuoka City, Japan, in 
1997, and the ser gene was shown to be located on a family of closely related plasmids, termed pF5 
and pF5-like. These plasmids have similar restriction profiles and carry selj along with ser. More 
recently, two novel SE genes (ses and set) have also been detected on the Fukuoka plasmids [40,93]. 
Interestingly, the ser gene, together with sed and selj, has also been found in pIB485-like plasmids 
from laboratory strains, food poisoning outbreak isolates and healthy human isolates in Japan [93] and 
pIB485-like plasmids, varying in size and/or restriction profile were present in S. aureus  isolates Toxins 2010, 2     
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recovered in Spain from human nasal carriers and manually handled foods [95]. Two of them, named 
pUO-Sa-SED1 (~33 kb) and pUO-Sa-SED2 (~36 kb), carried sed, selj and ser, and have restriction 
patterns identical or similar to that of pIB485, while pUO-Sa-SED3 (53.5 kb; containing sed, selj and 
ser-like) has a different profile. A BLAST search (http://www.ncbi.nlm.nih.gov) of the sed, selj, ser, 
ses and set genes revealed additional pIB485-like and pF5-like plasmids obtained from human clinical 
isolates, whose sequences have been deposited in databases. At present, the evolutionary relationship 
between the two types of plasmids is unknown. 
2.4.2. Prophages 
Like most published S. aureus phages, those carrying se genes (sea, selk, selp and selq) belong to 
the Siphoviridae family. The temperate, tailed bacteriophages within this family have been classified 
according to three features [96]: (i) the lysogeny module, particularly the integrase that dictates the 
insertion site of the phage in the bacterial chromosome; (ii) the serogroup, based on differences in 
capsid, tail, and tail appendix proteins; and (iii) the holin gene of the lysis module. The Siphoviridae 
prophages carrying se genes belong to integrase group Sa3, serogroups Fa and Fb, and holin groups 
255a and 255b. Three se/sel genes (sea, selk and selq) are present together in ФSa3ms and ФSa3mw, 
while a single se/sel gene (sea or selp) is carried by other prophages (Table 1; Figure 2).  
Apart from enterotoxins, virulence factors involved in evasion of the innate immunity are also 
encoded on these phages. These include the chemotaxis inhibitory protein (CHIP, product of the chp 
gene) that binds to host chemokine receptors, particularly the C5a receptor and the formylated peptide 
receptor, preventing neutrophil chemotaxis and activation [97]; the staphylococcal complement 
inhibitor (SCIN, encoded by the scn gene) that interferes with all pathways of complement activation 
by blocking C3 convertases [98]; the staphylokinase (product of the sak gene) that leads to degradation 
of two major opsonins (IgG and C3b) through activation of surface-bound plasminogen into plasmin, 
and also inhibits the bactericidal effect of α-defensins [99,100]. The region encoding these virulence 
factors is known as the "innate inmune evasion cluster" [101] and is located at one or both ends of the 
phages. Integration of these phages into the S. aureus  chromosome occurs by a site-specific 
recombination event between the attP site in the phage genome and the attB site located within the  
β-hemolysin gene in the bacterial chromosome [102]. While integration negatively converts   
β-hemolysin expression, it supplies other virulence genes. 
2.4.3. Staphylococcus aureus Pathogenicity Islands 
The SaPIs are mobile pathogenicity islands, which are widely distributed in S. aureus and have also 
been found in other species of Staphylococcus. SaPIs have a highly conserved overall organization, 
parallel to that of typical temperate bateriophages. Each one occupies a specific chromosomal site 
(attS), and always appears in the same orientation. From its integration site, the island can be induced to 
excise and replicate by one or more specific staphylococcal helper phages [103,104]. Following 
replication the SaPI DNA is efficiently encapsidated into infectious small-headed phage-like particles 
resulting in extremely high transfer frequencies. Toxins 2010, 2     
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Figure 2.  Enterotoxin genes carried by prophages  based on sequencing data deposited 
under the accession numbers indicated to the right of the figure. 
phage  genes enterotoxin genes
integrase genes
other virulence genes
phage attachment site
ФSa252B 
≈600-800 nt
ФSa3mw 
ФSa3ms
ФNM3
ФMu50A
ФSa3n 
ФMu3A
sea prophages
selp prophages
sea, selk, selq prophages
ФSaTW20
Ф04-02981 
MW2                    NC_003923.1
MSSA476            NC_002953.3
MRSA 252          NC_002952.2
Newman              NC_009641.1
Mu50                   NC_002758.2
N315                    NC_002745.2
Mu3                     NC_009782.1
Strain            Accession number
TW20                  FN433596.1
04-02981             CP001844
 
Figure 3.  Staphylococcus aureus  pathogenicity islands (SaPIs)  carrying enterotoxin or 
enterotoxin-like genes. Modified from Novick and Subedi [105] and based on the accession 
numbers indicated to the right of the figure. 
common genes to all SaPIs
other enterotoxin genes
terminase genes
integrase genes
initiator protein (helicase or primase) genes
Escherichia coli ampicillin resistance gene
SaPI1
attR attL
SaPI3
attR attL
SaPIm1/n1
attR attL
SaPI5
attR attL
SaPImw2
attR attL
SaPIbov1
attR attL
≈600-800 nt
Mu3                                   NC_009782.1
Mu50                                 NC_002758.2
N315                                  NC_002745.2
MW2                                 NC_003923.1
COL                                   CP000046.1
USA300_FPR3757            CP000255.1
USA300_TCH1516           NC_010079.1
RN4282                             U93688
RF122                                AJ938182
Strain                      Accession number SaPI
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SaPIs are very common in S. aureus  (Table 1). They range in size from 15–17  kb, with the 
exceptions of SaPIbov2 (27 kb) and a highly degenerated SaPI (3.14 kb) present in some sequenced 
genomes. The complete nucleotide sequence is known for 20 SaPIs, and some of them carry genes 
encoding TSST-1 and/or one or more SEs (Figure 3). For instance, tst is found together with selk and 
selq in SaPI1, with sec3 and sell in SaPIm1 and SaPIn1, and with sell and sec in SaPIbov1; seb, selq 
and selk have been reported in SaPI3; selk and selq in SaPI5; and sec4 and sell2 in SaPImw2 [105]. 
Induction of a SaPI is likely to originate an increase in the copy number of the toxin genes, and 
therefore to an increase in toxin production, as described for lysogenic phages [106]. 
2.4.4. vSa Genomic Islands 
The term vSa refers to non-phage and non-SCC genomic islands that are exclusively present in  
S. aureus, often (but not always) encode virulence determinants, are inserted at specific loci in the 
chromosome and are associated with either intact or remnant DNA recombinases [107,108]. Two 
major vSa genomic islands, namely vSaα and vSaβ, each of about 20–30 kb, are present in all S. aureus 
genomes sequenced so far, but absent in other Staphylococcus  species, including S. epidermidis. 
Though vSaα and vSaβ could have been acquired by horizontal gene transfer, actually there is not 
evidence that they can move.  Each  of these islands carries two copies of the genes encoding the 
recognition (hsdS) and methylation (hsdM) subunits of the Sau1 type I restriction-modification system. 
A single copy of the gene for the restriction subunit is located elsewhere in the S. aureus chromosome 
[109]. The hsdS genes of the Sau1 system diverge significantly between members of different lineages 
and this determines variations in the sequences  that will be specifically recognized as  targets  for 
modification through methylation. Since only modified sequences will be protected against restriction, 
exchange of DNA between members of same lineage will be allowed, while DNA transferred between 
isolates of different lineages will be digested. Because of this, the Sau1 system has been considered as 
a key factor in the control of lineage evolution. 
Figure 4. Structure of two types of the vSaβ genomic island containing the enterotoxin 
gene cluster. Adapted from Baba et al. [108] and based on accession numbers indicated to 
the right of the figure. 
common genes to all vSaβ types
other genes encoding a type I restriction-modification system lantibiotic biosynthesis genes
serine protease genes leukocidin genes
enterotoxin genes
tRNA
vSaβ type I
tRNA
vSaβ type III
vSaβ
≈600-800 nt
Strain            Accession number
Mu3                     NC_009782.1
Mu50                   NC_002758.2
N315                    NC_002745.2
ED98                   CP001781.1
TW20                  FN433596.1
JH1                      CP000736.1
JH9                      NC_009487.1
04-029021           CP001844
MRSA252           NC_002952.2
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Both vSaα and vSaβ contain clusters of genes encoding known or putative virulence factors. vSaα 
carries a cluster of lipoprotein-encoding genes (lpl cluster), and the set (staphylococcal exotoxin-like) 
cluster [55,110], later re-named as the ssl  (staphylococcal superantigen-like) cluster [30]. The ssl 
cluster consists of a series of related genes (between 7 and 11) coding for proteins that share a common 
architecture with SAgs but do not function as such [50]. However, they have alternative effects on the 
host immune system, acting on IgA, complement factor C5 (as demonstrated for SSL7; [53]), or 
neutrophils (SSL5 [111] and SSL11 [52]). vSaβ carries a serine protease gene (spl) cluster, genes for 
the components of the LukED leukocidin (lukD and lukE), genes for lantibiotic biosynthesis (bsa) 
and/or the enterotoxin gene cluster (egc), which includes a variable number of se/sel genes forming an 
operon [36]. Two representative types of vSaβ, the genomic island carrying se genes, are showed in 
Figure 4. 
It has been suggested that the egc  cluster arose from an ancestral se  gene, through tandem 
duplication and further variation, while gene recombination has created variant toxins with different 
biological activities [28,36,112]. The dynamic evolution of this cluster that has been considered as a 
nursery of se/sel genes [36] is reflected in the number of variants already known (Figure 5). 
Figure 5. Structure of egc clusters. Modified from Thomas et al [28] and Collery et al. 
[114], and based on the accession numbers indicated to the right of the figure. 
enterotoxin genes transposase genes
egc1
egc3
egc4
egc2
egc variants with IS
egcvariants
A900322              AF285760, DQ993159
FR1572               AF156894
Mu50                   NC_002758.2
N315                    NC_002745.2
382F                    AY158703
MRSA252           NC_002952.2 
RF122                  NC_007622.1
383F                    AY205306
352E                    AY205305
FRI137                AY205307
A950227
LY1991222 
A940440                                 
A980341                               
LY1991287
Strain            Accession number
A900624             EF030427, EF030428
 
The first egc (egc1) was discovered in 2001 and consists of two SE genes (seg and sei), three SEl 
genes (selm, seln and selo), and two pseudogenes (φent1 and φent2) [36,113]. Afterward, a second egc 
variant (egc2) containing an additional SEl gene (selu) was described [37]. The latter gene has been Toxins 2010, 2     
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generated by fusion of the two egc1 pseudogenes, due to a 15 nucleotide insertion in φent1 and a single 
adenine deletion that abolishes a stop codon within the same gene. In addition, allelic variants of each 
of the egc2 genes compose the egc3 cluster [37,114,115], and a new selu variant (selu2) and a novel sel 
gene (selv) are present in egc4 [28]. A recombination event between selm and sei produced selv, while 
deletion of one adenine between the overlapping 5’ and 3’ ends of the φent2 and φent1 pseudogenes 
generated selu2 (which was proposed to be renamed as selw) [116]. Incomplete egc clusters, lacking 
one or more genes of the classical egc1, as well as variants carrying insertion sequences within seln, 
seg or sei, have also been described [28,117]. These structures have been considered as evolutionary 
intermediates of the egc cluster [28]. Moreover, the fact that each of the three major homology groups 
of SEs/SEs (Table 2) contains enterotoxins encoded by genes of the egc operon led to the proposal that 
all se/sels originated from the egc cluster [29]. 
2.4.5. Enterotoxin Genes in the Proximity of the Staphylococcal Cassette Chromosome 
The seh gene, flanked by a truncated selo gene and a putative transposase gene, have been found in 
close proximity of the non-mecA containing SCC element harbored by MSSA (methicillin susceptible 
S. aureus) strain 476; the SCCmec type IV of S. aureus MW2; and the SCCmec type IV of a collection 
of highly related community-associated S. aureus ([118]; Figure 6). In the latter strains, acquisition of 
the seh element could have stabilized the integration of SCCmec type IV, which is unable to excise [118]. 
Figure 6. Comparison of two allelic forms of SCC elements associated with seh. Modified 
from Noto and Archer [118] and based on the accession numbers indicated to the right of  
the figure. 
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2.5. Staphylococcal Enterotoxins and Food Poisoning Outbreaks 
Independently of their origin, enterotoxigenic S. aureus often differ in the number of mobile genetic 
elements and se/sel genes therein, as well as in the enterotoxins they produce. SEA, either alone or 
together with other SEs/SEls, is the enterotoxin most commonly reported in foods, and is also 
considered as the main cause of SFP, probably due to its extraordinarily high resistance to proteolytic 
enzymes [3,119,120]. The predominance of SEA is well documented in different countries. As relevant 
examples: (i) a comprehensive study of 359 outbreaks that occurred in the United Kingdom (UK) 
between 1969 and 1990 revealed that 79% of the S. aureus strains produced SEA [121]. Meat, poultry Toxins 2010, 2     
 
1762 
and their products, particularly ham and chicken, were the vehicle in 75% of the incidents. SEA was 
detected alone in 56.9% of the outbreaks and, in conjunction with SED, SEB, SEC or SEB and SED in 
a lower number of outbreaks (15.4, 3.4, 2.5 or 1.1%, respectively); (ii) SEA was also the enterotoxin 
most frequently found among 31 SFP outbreaks in France (69.7%), which were associated with a great 
variety of foods including milk products, different types of meat, and salads, between 1981 and 2002 
[122]. In agreement with this, sea was the most common gene in the isolates tested, followed by sed, 
seg, sei and she; (iii) In Austria, an SFP outbreak that affected 40 children in 2007 was attributed to  
S. aureus isolates producing SEA and SED. Bovine milk products were identified as the source of the 
outbreak, and the cows, not the dairy owner, were the more likely reservoir of the SEs-producing  
S. aureus [123]; (iv) SEA was also the most common enterotoxin recovered from food poisoning 
outbreaks in USA (77.8% of all outbreaks) followed by SED and SEB [124]; (v) A study of S. aureus 
obtained from dairy products, responsible for 16 outbreaks in Brazil revealed that the most frequently 
encountered enterotoxin gene was sea  followed by seb  [125]. Finally, (vi) several studies have 
investigated the distribution of SEs and se/sel genes in S. aureus from foods and SFP outbreaks in 
Asian countries. Among strains recovered from patients associated with SFP outbreaks during   
2001-2003 in Taiwan, sea was the most common gene, followed by seb and sec [13]. In Korea, about 
90% of food poisoning isolates were reported to contain the sea gene [126]. SEA also was the most 
common SE associated to SFP in Japan [127]. In this country, an extensive outbreak that occurred in 
2000 was attributed to low-fat milk containing SEA [128], while a recent outbreak (2009) was due to 
crepes containing SEA and SEC [129]. 
SEB, SEC or SED alone  have been also implicated in SFP outbreaks  through the world 
[121,122,125]. Interestingly, an outbreak, which affected three members of the same family in USA, 
was caused by coleslaw-containing SEC produced by a community-acquired  methicillin resistant   
S. aureus from an asymptomatic food handler [130]. The fifth classical enterotoxin, SEE, has been 
infrequently reported in foods and food-producing animals, and its involvement in SFP outbreaks has 
only been demonstrated in rare occasions. However, six SFP outbreaks, which occurred in France at 
the end of 2009, were caused by SEE present in soft cheese made from unpasteurized milk. This 
enterotoxin has also been associated with outbreaks in USA and UK [33,121,131–133]. 
In contrast to classical SEs, the relationship between the novel SEs/SEls and SFP is not fully 
understood. Among them, SEG, SEH and SEI, SER, SES, and SET have shown to be emetic after oral 
administration  in a primate model, while the emetic activity of SElL and SElP has only  been 
demonstrated in rabbits and the small insectivore Suncus murinus, respectively [39,43]. The remaining 
SEls either lack emetic properties (SElQ), or have not been tested (SElJ, SElK, SElM, SElN, SElO, 
SElU, SElU2 and SElV). Moreover, commercial kits are not available for immunological detection of 
these SEs and SEls, although ELISA (enzyme-linked immunosorbent assay) has been described for 
SEH [134] and for SEG and SEI [135]. Of the new enterotoxins, only SEH-producing strains have 
clearly been involved in SFP outbreaks [134,136–138], but results from different researchers have 
shown  the  high incidence of genes encoding  new SEs and SEls  among food-borne  S. aureus  
[131,139–141]. Mc Lauchlin et al. [131] revealed that 23 staphylococcal strains implicated in SFP 
outbreaks in UK, in which classical se genes were not detected, harbored one or more of the new se/sel 
genes, i.e., seg, seh, sei or selj. It is possible that the corresponding SEs might have been the cause of Toxins 2010, 2     
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these outbreaks. The presence of egc genes was also shown in food-associated S. aureus from other 
countries [131,140–144], and newly described SE or SEl genes, particularly those belonging to the egc 
cluster, were more frequently detected in S. aureus strains isolated from raw pork and chicken meat in 
Korea than genes encoding classical SEs [145]. Despite this, egc-encoded SEs or SEls have not yet 
been directly implied in typical cases of SFP, although SEG and SEI have been reported as the cause of 
chronic  diarrhea associated with severe but reversible enteropathy  in  two  malnourished  
neonates [146]. 
3. Conclusions 
SEs and SEls produced by S. aureus  belong to the fascinating family of superantigens, which 
sabotage the immune system of the host by targeting the innate and adaptive responses. Members of 
the family are well characterized with regard to superantigenic activity. However, the bases for the 
enterotoxigenic activity associated with a number of S. aureus superantigens remain elusive. Likewise, 
a direct relationship of S. aureus SEs (with demonstrated emetic activity) and SEls (which lack emetic 
activity or have yet to be tested) with pathogenicity has not always been established, and the reasons 
for the redundancy of se/sel genes within the same bacterium deserve further attention. Of particular 
interest is the egc cluster, regarded as a nursery of se/sel genes in continuing evolution. The cluster and 
its multiple variants, located on the νSaβ genomic island, are widely distributed in S. aureus of any 
origin, and results from our group indicate that they are the most common superantigenes in S. aureus 
recovered from clinical samples, healthy carriers, cows with subclinical mastitis  and  
foods [143,147–149]. However, a direct involvement of egc-encoded SEs in food poisoning has not 
been demonstrated, and attempts to elucidate their pathogenic role are still scarce [146,150–152]. In 
summary, although a wealth of information on SEs and SEls is already available, they still represent an 
active field of research, which will certainly provide new exciting findings in forthcoming years. 
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